On July 3, Zhiyao Yuanchuang Medical Technology (Shanghai) Co., Ltd. officially held its opening ceremony, inviting experts from academia and industry to witness this important moment.

The experts who took time out of their busy schedules to attend, signing their names to offer their blessings and affirmation for our opening, and leaving behind valuable suggestions and visions. This not only added luster to our opening ceremony but also affirmed and blessed our business. After the exchange and discussion, we officially began our opening ceremony.

Gu Jianping, Party Secretary of the School of Life Sciences and Biotechnology at Shanghai Jiao Tong University, expressed his hope that the company will continue to grow and play a positive role in the development of the pharmaceutical industry. Secretary Gu emphasized that Shanghai Jiao Tong University has always kept pace with national policies and, as a pioneer in technology transfer, is committed to stimulating and promoting the marketization of faculty members' innovative achievements to realize broader social value.

Professor Chen Haifeng, the company's founder, provided an in-depth introduction to our core technologies to the guests present. Zhiyao Yuanchuang focuses on the innovative design and development of protein drugs. Leveraging our advanced proprietary algorithms and R&D pipeline, we have already achieved a series of remarkable results. Professor Chen's detailed presentation not only gave industry partners a clearer understanding of our business scope but also laid a solid foundation for future cooperation. Through this sharing, we look forward to working with all parties to jointly usher in a new chapter of pharmaceutical innovation.

Following this, Professor Yu Zhangsheng, the company's founder, gave a concise introduction to the company. He explained the profound meaning behind the name "Zhiyao Yuanchuang," which originates from the motto of Shanghai Jiao Tong University, "Siyuan Zhiyuan" (思源致远), taking the characters "Zhi" (致) and "Yuan" (源) to convey a deep meaning. Both founders are distinguished professors at Shanghai Jiao Tong University, and they have integrated academic wisdom and innovative spirit into the company culture. The name "Zhiyao Yuanchuang" not only signifies that the company is a model for incubating scientific research achievements of Shanghai Jiao Tong University, but also affirms the team's groundbreaking progress in the field of protein drug design using artificial intelligence technology. The name "Zhiyao Yuanchuang" embodies the inheritance of the spirit of Shanghai Jiao Tong University, demonstrates our ambition and determination in the field of pharmaceutical innovation, and showcases the core team's professional level and boundless vision for the future.

At 15:58, the ceremony officially began, and we are full of expectations for the future development of Zhiyao Yuanchuang. To create a relaxed and friendly environment, we have prepared exquisite refreshments, including a variety of desserts and drinks, in order to provide our guests with a pleasant atmosphere for discussion.

Next, we were honored to have Dr. Chen Chunlin for an in-depth exchange. As the founder and chief scientific officer of Medicilon, Dr. Chen shared the advanced model of AI+CRO (Contract Research Organization) collaboration, providing valuable industry insights for the attendees. The launch of Medicilon's Corporate Open Innovation Center aims to promote the transformation of scientific research results, and Dr. Chen also expressed his vision of working with us to create a shared future. Furthermore, as an important member of the Zhangjiang AI New Drug R&D Alliance, Dr. Chen detailed the alliance's goals and mission, showcasing its crucial role in driving industry development. Professor Yu emphasized the importance of speed and efficiency for our company's development during the exchange, highly praising the profound significance of collaborating with Dr. Chen, and the necessity of strengthening industry alliances and jointly promoting pharmaceutical innovation.

Furthermore, we were honored to have Dr. Zhou Jian from Shanghai Sixth People's Hospital engage in an in-depth discussion on the development prospects of GLP-1 and peptide drugs. Dr. Zhou pointed out that the incidence of diabetes in my country continues to rise, and there are currently no signs of stabilization. According to the latest statistics, approximately 12% of the population suffers from diabetes, highlighting the urgency of GLP-1 drug development and its continued demand in the future market. Dr. Zhou, with his extensive experience and profound insights into current medical trends, provided valuable clinical advice and professional guidance for our company's business development, pointing the way for our future research directions and pipeline planning.

At the ceremony, Dr. Cui Jinhui of Suzhou Perrotin Biotechnology Co., Ltd. emphasized the efficiency of artificial intelligence in drug design and screening. He pointed out that the application of AI technology has greatly optimized the drug development process and improved the accuracy and speed of screening. Dr. Cui also mentioned that his company can provide in-depth analysis at the wet laboratory level, which will strongly complement our research and jointly accelerate the entire R&D process, enabling us to achieve our goals more quickly.

Finally, we invited Professor Pan Xueqi from Jiaotong University Science Park to participate in the ceremony. Professor Pan expressed her gratitude for the opportunity to gain a deeper understanding of this field, emphasizing that drug health is an area of ​​great concern to human society. She also mentioned that the introduction of AI technology has accelerated the drug discovery process, a advancement of great significance to the entire industry.

With the successful conclusion of the opening ceremony, SmartPharma Innovation has embarked on a new chapter. We are committed to leveraging AI technology to empower drug innovation and lead the future of the healthcare industry. We will continue to strive and innovate, dedicated to creating unique value for every customer through our products and services.